Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis

Leukemia

Volumn 28, Issue 5, 2014, Pages 1152-1154

  Chi, J ^a   Nicolaou, K A ^a   Nicolaidou, V ^a   Koumas, L ^a,b   Mitsidou, A ^a,b   Pierides, C ^a   Manoloukos, M ^a   Barbouti, K ^a   Melanthiou, F ^c   Prokopiou, C ^d   Vassiliou, G S ^a,e   Costeas, P ^a,b  

^a The Center for the Study of Haematological Malignancies   (Cyprus)

^b Karaiskakio Foundation   (Cyprus)

^c NICOSIA GENERAL HOSPITAL   (Cyprus)

^d LIMASSOL GENERAL HOSPITAL   (Cyprus)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CALRETICULIN; COMPLEMENTARY DNA; GENOMIC DNA; GLUTAMIC ACID; GLYCOPROTEIN VI; INTERLEUKIN 3; THROMBOSPONDIN 1; VERY LATE ACTIVATION ANTIGEN 2;

AGAR GEL ELECTROPHORESIS; AMINO ACID SEQUENCE; CALCIUM HOMEOSTASIS; CAPILLARY ELECTROPHORESIS; CELL MATURATION; CODON; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; EXON; FOCAL ADHESION; FRAMESHIFT MUTATION; GEL ELECTROPHORESIS; GENE IDENTIFICATION; HEMOGLOBIN DETERMINATION; HUMAN; INDEL MUTATION; KERATINOCYTE; LETTER; MEGAKARYOCYTE; MYELOFIBROSIS; MYELOPROLIFERATIVE NEOPLASM; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TANDEM REPEAT; THROMBOCYTHEMIA; THROMBOCYTOPOIESIS; THROMBOCYTOSIS; WOUND HEALING;

BASE SEQUENCE; CALRETICULIN; DNA PRIMERS; DNA, COMPLEMENTARY; EXONS; FRAMESHIFT MUTATION; HUMANS; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, NUCLEIC ACID; THROMBOCYTOSIS;

EID: 84899953653     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.382     Document Type: Letter

References (15)

1. Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC. et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 2013; 369: 2391-2405.
2. Klamfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD. et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 2013; 369: 2379-2390.
3. Michalak M, Corbett EF, Mesaeli N, Nakamura K, Opas M. Calreticulin: One protein, one gene, many functions. Biochem J 1999; 344(Pt 2): 281-292.
4. Gold LI, Eggleton P, Sweetwyne MT, Van Duyn LB, Greives MR, Naylor SM. et al. Calreticulin: Non-endoplasmic reticulum functions in physiology and disease. FASEB J 2010; 24: 665-683.
5. Baksh S, Michalak M. Expression of calreticulin in Escherichia coli and identification of its Ca2+ binding domains. J Biol Chem 1991; 266: 21458-21465.
6. Kuwabara K, Pinsky DJ, Schmidt AM, Benedict C, Brett J, Ogawa S. et al. Calreticulin, an antithrombotic agent which binds to vitamin K-dependent coagulation factors, stimulates endothelial nitric oxide production, and limits thrombosis in canine coronary arteries. J Biol Chem 1995; 270: 8179-8187.
7. Lopez JJ, Palazzo A, Chaabane C, Albarran L, Polidano E, Lebozec K. et al. Crucial role for endoplasmic reticulum stress during megakaryocyte maturation. Arterioscler Thromb Vasc Biol 2013; 33: 2750-2758.
8. Goicoechea S, Pallero MA, Eggleton P, Michalak M, Murphy-Ullrich JE. The anti-Adhesive activity of thrombospondin is mediated by the N-Terminal domain of cell surface calreticulin. J Biol Chem 2002; 277: 37219-37228.
9. Nanney LB, Woodrell CD, Greives MR, Cardwell NL, Pollins AC, Bancroft TA. et al. Calreticulin enhances porcine wound repair by diverse biological effects. Am J Pathol 2008; 173: 610-630.
10. Elton CM, Smethurst PA, Eggleton P, Farndale RW. Physical and functional interaction between cell-surface calreticulin and the collagen receptors integrin alpha2beta1 and glycoprotein VI in human platelets. Thromb Haemost 2002; 88: 648-654.
11. Coe H, Jung J, Groenendyk J, Prins D, Michalak M. ERp57 modulates STAT3 signaling from the lumen of the endoplasmic reticulum. J Biol Chem 2010; 285: 6725-6738.
12. Zapun A, Darby NJ, Tessier DC, Michalak M, Bergeron JJ, Thomas DY. Enhanced catalysis of ribonuclease B folding by the interaction of calnexin or calreticulin with ERp57. J Biol Chem 1998; 273: 6009-6012.
13. Senyuk V, Rinaldi CR, Li D, Cattaneo F, Stojanovic A, Pane F. et al. Consistent up-regulation of Stat3 Independently of Jak2 mutations in a new murine model of essential thrombocythemia. Cancer Res 2009; 69: 262-271.
14. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H. et al. (eds) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn. World Health Organisation: Geneva, Switzerland, 2008.
15. Harrison CN, Bareford D, Butt N, Campbell P, Conneally E, Drummond M. et al. Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol 2010; 149: 352-375.